Nanjing Vishee Medical Technology Co Ltd
SSE:688580
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
20.7
66.0932
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Nanjing Vishee Medical Technology Co Ltd
Nanjing Vishee Medical Technology Co Ltd
Accounts Receivables
Nanjing Vishee Medical Technology Co Ltd
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Nanjing Vishee Medical Technology Co Ltd
SSE:688580
|
Accounts Receivables
¥36.6m
|
CAGR 3-Years
42%
|
CAGR 5-Years
147%
|
CAGR 10-Years
N/A
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Accounts Receivables
¥41.4m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Accounts Receivables
¥1.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
6%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Accounts Receivables
¥4B
|
CAGR 3-Years
28%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jafron Biomedical Co Ltd
SZSE:300529
|
Accounts Receivables
¥72m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Accounts Receivables
¥3.3B
|
CAGR 3-Years
67%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Nanjing Vishee Medical Technology Co Ltd
Glance View
Nanjing Vishee Medical Technology Co., Ltd. manufactures electrical and magnetic stimulators for pelvic floor, postnatal, neurological and mental rehabilitation. The company is headquartered in Nanjing, Jiangsu and currently employs 575 full-time employees. The company went IPO on 2020-07-21. The Company’s products are mainly electrical stimulation, magnetic stimulation, electrophysiological equipment, consumables and accessories and other rehabilitation medical equipment and products, such as pelvic floor muscle recovery equipment, transcranial magnetic stimulator, neonatal electroencephalography measuring instrument, rectal electrode, micro current stimulator and others. The firm mainly conducts its businesses within the domestic market.
See Also
What is Nanjing Vishee Medical Technology Co Ltd's Accounts Receivables?
Accounts Receivables
36.6m
CNY
Based on the financial report for Dec 31, 2023, Nanjing Vishee Medical Technology Co Ltd's Accounts Receivables amounts to 36.6m CNY.
What is Nanjing Vishee Medical Technology Co Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
147%
Over the last year, the Accounts Receivables growth was 73%. The average annual Accounts Receivables growth rates for Nanjing Vishee Medical Technology Co Ltd have been 42% over the past three years , 147% over the past five years .
You don't have any saved screeners yet
